Email Updates

Search form

You are here

AVAC in the News

  • In a landmark advancement against AIDS, federal authorities Monday made a drug from Gilead Sciences, a California company, the world's first approved medication to help prevent the spread of HIV.

    July 17, 2012
    San Jose Mercury News
  • A follow-up study on an AIDS vaccine trial that had to be stopped early has confirmed the worst fears of researchers: The vaccine made it more likely, not less, that some men would become infected with HIV.

    May 18, 2012
    New York Times
  • Just last week, an advisory committee to the US Food and Drug Administration recommended approval of the antiretroviral TDF/FTC for pre-exposure prophylaxis (PrEP) in HIV-negative adults. A final decision from the FDA is expected in June -- and approval would provide another powerful option for HIV prevention.

    May 17, 2012
    Huffington Post
  • Truvada combina dos medicamentos antirretrovirales que pueden reducir el riesgo de contagio de la enfermedad en un 73%.

    May 11, 2012
    Peru21
  • Could we be one step closer to a world without HIV AIDS?Hopes are rising after a panel of US health experts has, for the first time, backed a drug to prevent HIV infection in healthy people.

    May 11, 2012
    ABC Radio Australia
  • The US Food and Drug Administration (FDA) took a decisive step yesterday towards approving the use of the combination pill Truvada (tenofovir/FTC) as a prevention method for HIV-negative people.

    May 11, 2012
    aidsmap
  • Truvada is safe and effective enough as a preventative medicine, Food and Drug Administration staff concluded in a report yesterday.

    May 9, 2012
    Bloomberg News
  • Recent studies have shown that antiretroviral drugs can be used not only to treat HIV, but also to prevent infection in the first place.

    April 25, 2012
    Voice of America
  • The story of pre-exposure prophylaxis for HIV -- using medications to prevent infection -- was anything but easy to understand at the CROI.

    March 12, 2012
    MedPage Today
  • The failure of a daily pill to protect healthy African women against AIDS may not have been the pill’s fault but the women’s reluctance to take it, scientists at an important AIDS conference in Seattle were told this week.

    March 12, 2012
    New York Times

Pages